Literature DB >> 14660734

Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Shlomo Melmed1.   

Abstract

The anterior pituitary gland integrates the repertoire of hormonal signals controlling thyroid, adrenal, reproductive, and growth functions. The gland responds to complex central and peripheral signals by trophic hormone secretion and by undergoing reversible plastic changes in cell growth leading to hyperplasia, involution, or benign adenomas arising from functional pituitary cells. Discussed herein are the mechanisms underlying hereditary pituitary hypoplasia, reversible pituitary hyperplasia, excess hormone production, and tumor initiation and promotion associated with normal and abnormal pituitary differentiation in health and disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14660734      PMCID: PMC281651          DOI: 10.1172/JCI20401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  140 in total

1.  Somatic mutation of TRbeta can cause a defect in negative regulation of TSH in a TSH-secreting pituitary tumor.

Authors:  S Ando; N J Sarlis; E H Oldfield; P M Yen
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

2.  Cohesin cleavage by separase required for anaphase and cytokinesis in human cells.

Authors:  S Hauf; I C Waizenegger; J M Peters
Journal:  Science       Date:  2001-08-17       Impact factor: 47.728

3.  Tbx19, a tissue-selective regulator of POMC gene expression.

Authors:  J Liu; C Lin; A Gleiberman; K A Ohgi; T Herman; H P Huang; M J Tsai; M G Rosenfeld
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

4.  Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study.

Authors:  P Chanson; F Daujat; J Young; A Bellucci; M Kujas; D Doyon; G Schaison
Journal:  J Clin Endocrinol Metab       Date:  2001-07       Impact factor: 5.958

5.  Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division.

Authors:  Z Wang; R Yu; S Melmed
Journal:  Mol Endocrinol       Date:  2001-11

6.  Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4.

Authors:  K Machinis; J Pantel; I Netchine; J Léger; O J Camand; M L Sobrier; F Dastot-Le Moal; P Duquesnoy; M Abitbol; P Czernichow; S Amselem
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

7.  Absence of constitutively activating mutations in the GHRH receptor in GH-producing pituitary tumors.

Authors:  E J Lee; T J Kotlar; I Ciric; M K Lee; S K Lim; H C Lee; K B Huh; K E Mayo; J L Jameson
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

8.  Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment.

Authors:  E Ballarè; L Persani; A G Lania; M Filopanti; E Giammona; S Corbetta; S Mantovani; M Arosio; P Beck-Peccoz; G Faglia; A Spada
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

9.  Longitudinal imaging reveals pituitary enlargement preceding hypoplasia in two brothers with combined pituitary hormone deficiency attributable to PROP1 mutation.

Authors:  F G Riepe; C J Partsch; O Blankenstein; H Mönig; R W Pfäffle; W G Sippell
Journal:  J Clin Endocrinol Metab       Date:  2001-09       Impact factor: 5.958

Review 10.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

View more
  143 in total

Review 1.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

2.  Phosphoproteomic analysis of the human pituitary.

Authors:  Sarka Beranova-Giorgianni; Yingxin Zhao; Dominic M Desiderio; Francesco Giorgianni
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  Cyclin-dependent kinase inhibitor gene polymorphisms in pituitary gigantism.

Authors:  Run Yu; Vivien Bonert; Martha Cruz-Soto; Shlomo Melmed
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

4.  The dependence receptor Ret induces apoptosis in somatotrophs through a Pit-1/p53 pathway, preventing tumor growth.

Authors:  Carmen Cañibano; Noela L Rodriguez; Carmen Saez; Sulay Tovar; Montse Garcia-Lavandeira; Maria Grazia Borrello; Anxo Vidal; Frank Costantini; Miguel Japon; Carlos Dieguez; Clara V Alvarez
Journal:  EMBO J       Date:  2007-03-22       Impact factor: 11.598

Review 5.  Pituitary stem cell update and potential implications for treating hypopituitarism.

Authors:  Frederic Castinetti; Shannon W Davis; Thierry Brue; Sally A Camper
Journal:  Endocr Rev       Date:  2011-04-14       Impact factor: 19.871

6.  Hypothalamic input is required for development of normal numbers of thyrotrophs and gonadotrophs, but not other anterior pituitary cells in late gestation sheep.

Authors:  Eva Szarek; Kirsten Farrand; I Caroline McMillen; I Ross Young; Daniel Houghton; Jeffrey Schwartz
Journal:  J Physiol       Date:  2007-12-20       Impact factor: 5.182

Review 7.  Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.

Authors:  N Karavitaki; B W Scheithauer; J Watt; O Ansorge; M Moschopoulos; A V Llaguno; J A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

8.  Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Authors:  Odelia Cooper; Adam Mamelak; Serguei Bannykh; John Carmichael; Vivien Bonert; Stephen Lim; Galen Cook-Wiens; Anat Ben-Shlomo
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

9.  Pediatric giant pituitary adenomas: are they different from adults? A clinical analysis of a series of 12 patients.

Authors:  Sumit Sinha; Avijit Sarkari; A K Mahapatra; B S Sharma
Journal:  Childs Nerv Syst       Date:  2014-04-29       Impact factor: 1.475

10.  The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.

Authors:  Seda Turgut; Muzaffer Ilhan; Saime Turan; Ozcan Karaman; Ilhan Yaylim; Ozlem Kucukhuseyin; Ertugrul Tasan
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.